Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Esophageal Neoplasms × Interleukin-2 × Clear all

Sponsor

Conditions

Melanoma 33 Neoplasm Metastasis 16 Leukemia, Myeloid, Acute 11 Skin Neoplasms 9 Leukemia 9 Kidney Neoplasms 9 Carcinoma, Renal Cell 9 Neoplasms 7 Ovarian Neoplasms 6 Breast Neoplasms 6 Lymphoma 5 Lymphoma, Non-Hodgkin 4 Congenital Abnormalities 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neuroblastoma 3 Myelodysplastic Syndromes 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Recurrence 2 Papillomavirus Infections 2 Lymphoma, Mantle-Cell 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vulvar Diseases 1

Interventions

Fluorouracil 32 Cisplatin 32 Radiotherapy 29 Oxaliplatin 28 Paclitaxel 20 Irinotecan 20 Docetaxel 20 pembrolizumab 19 Leucovorin 18 Capecitabine 16 Cetuximab 11 Bevacizumab 11 Carboplatin 10 Radiation 9 Trastuzumab 8 Surgical Procedures, Operative 8 Panitumumab 6 Epirubicin 5 Neoadjuvant Therapy 4 Esophagectomy 4 Erlotinib Hydrochloride 4 tisotumab vedotin 3 durvalumab 3 Sunitinib 3 Gemcitabine 3 Chemotherapy, Adjuvant 3 Albumin-Bound Paclitaxel 3 pegfilgrastim 2 niraparib 2 epacadostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡